MyNemours Sign-InTrial of Lenalidomide in Patients With Juvenile Pilocytic Astrocytomas & Optic Pathway Gliomas
Children's Oncology Group (COG)
Clinical Trial
Offered by: Nemours
Locations: Delaware Valley, Jacksonville, FL, Orlando, FL, Pensacola, FL
Trial Name
A Phase II Randomized Trial of Lenalidomide (NSC # 703813, IND # 70116) in Pediatric Patients With Recurrent, Refractory, or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
What is the trial about?
To find out what effects low and high doses of lenalidomide have on children, adolescents, and young adults with recurrent/refractory/progressive JPA or OPG.
Who can participate?
Children with juvenile pilocytic astrocytomas (JPA) or an optic pathway glioma (OPG).
What is involved?
Length of study is 24 months. Standard cancer care.
Contact Nemours Clinical Trials
Trial Name: A Phase II Randomized Trial of Lenalidomide (NSC # 703813, IND # 70116) in Pediatric Patients With Recurrent, Refractory, or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
COG#: ACNS1022
Contact Information
(800) 354-5690
ClinicalTrials@nemours.org